Decreasing Trends in Reye Syndrome and Aspirin Use in Michigan, 1979 to 1984
1 From the Michigan Department of Public Health, Lansing; Division of Field Services, Epidemiology Program Office and Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta; and Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor
The incidence of Reye syndrome has been decreasing in Michigan, perhaps as a result of decreased aspirin use among children. To evaluate possible changes in the frequency of aspirin use, 199 families in Tecumseh, MI, with children younger than 18 years of age were interviewed by telephone in February 1981 and again in February 1983. Based on the reported use of medications for colds or influenza between 1981 and 1983, fewer parents gave aspirin (56% v 25%), but acetaminophen use did not change (59% v 55%). Younger parents and parents who had heard of the association between aspirin and Reye syndrome were more likely to stop giving aspirin. More parents chose to use either no medication or medications containing neither aspirin nor acetaminophen (6% v 32%) for the treatment of colds or influenza. Approximately 90% of parents who chose not to give aspirin for fever also gave medications for colds or influenza that did not contain aspirin. These results suggest that fewer children are receiving aspirin during illnesses that may precede Reye syndrome. The associated decrease in the incidence of Reye syndrome tends to support the hypothesis that the use of aspirin increases the risk for the development of Reye syndrome.
Key Words: Reye syndrome aspirin varicella infection influenza infection medication preferences
Submitted on January 17, 1985
Accepted on March 4, 1985
This article has been cited by other articles:
![]() |
E. D. Belay, J. S. Bresee, R. C. Holman, A. S. Khan, A. Shahriari, and L. B. Schonberger Reye's Syndrome in the United States from 1981 through 1997 N. Engl. J. Med., May 6, 1999; 340(18): 1377 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Monto The Disappearance of Reye's Syndrome -- A Public Health Triumph N. Engl. J. Med., May 6, 1999; 340(18): 1423 - 1424. [Full Text] |
||||
![]() |
R. E. Kauffman Reye's Syndrome and Salicylate Use, by Karen M. Starko, MD, et al, Pediatrics, 1980;66:859-864; and National Patterns of Aspirin Use and Reye Syndrome Reporting, United States, 1980 to 1985, by Janet B. Arrowsmith et al, Pediatrics, 1987;79:858-863 Pediatrics, July 1, 1998; 102(1): 259 - 262. [Full Text] |
||||
![]() |
Reye Syndrome Surveillance--United States, 1989 JAMA, February 27, 1991; 265(8): 960 - 960. [PDF] |
||||
![]() |
Reye Syndrome Surveillance-- United States, 1987 and 1988 JAMA, June 23, 1989; 261(24): 3520 - 3523. [PDF] |
||||
![]() |
E. S. Hurwitz The Changing Epidemiology of Reye's Syndrome in the United States: Further Evidence for a Public Health Success JAMA, December 2, 1988; 260(21): 3178 - 3180. [Abstract] [PDF] |
||||
![]() |
E. Strauss Hepatitis Delta Virus Infection and Labrea Hepatitis JAMA, June 24, 1988; 259(24): 3559 - 3560. [Abstract] [PDF] |
||||
![]() |
S. E. STRAUS, J. M. OSTROVE, G. INCHAUSPE, J. M. FELSER, A. FREIFELD, K. D. CROEN, and M. H. SAWYER Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention Ann Intern Med, February 1, 1988; 108(2): 221 - 237. [Abstract] [PDF] |
||||
![]() |
D. G. Sienko, R. F. Anda, H. B. McGee, and P. L. Remington Reye's Syndrome and Salicylates JAMA, December 4, 1987; 258(21): 3119 - 3119. [Abstract] [PDF] |
||||
![]() |
Reye Syndrome Surveillance--United States, 1986 JAMA, November 20, 1987; 258(19): 2645 - 2648. [PDF] |
||||
![]() |
E. S. Hurwitz, M. J. Barrett, D. Bregman, W. J. Gunn, P. Pinsky, L. B. Schonberger, J. S. Drage, R. A. Kaslow, D. B. Burlington, G. V. Quinnan, et al. Public Health Service Study of Reye's Syndrome and Medications: Report of the Main Study JAMA, April 10, 1987; 257(14): 1905 - 1911. [Abstract] [PDF] |
||||
![]() |
J. M. Meythaler and R. R. Varma Reye's Syndrome in Adults: Diagnostic Considerations Arch Intern Med, January 1, 1987; 147(1): 61 - 64. [Abstract] [PDF] |
||||
![]() |
R. Glass New prospects for epidemiologic investigations Science, November 21, 1986; 234(4779): 951 - 955. [Abstract] [PDF] |
||||










